Welcome to The China Health Pulse newsletter and podcast, your go-to resource that diagnoses China's impact on patients, policy and the future of global health, serving a 3000+ strong audience across 80+ countries and 40+ US states: encompassing consultants, investors, biopharma, med-tech and global health leaders, as well as doctors, students and academics.
We have recently lived through a pandemic that reshaped the world and put China at the centre of global health, whether through supply chains, biotech breakthroughs or shifting policies.
The landscape is moving fast. But too often, the conversation swings between extremes. We’re either hit with breathless headlines - China dominates biotech! The US loses ground in global health! or buried under dense technical reports that make our eyes glaze over. We are missing a clear, informed and engaging perspective which connects the dots between policy, markets, and the human experiences on the ground.
Whether it’s a patient crying out for care in a crowded hospital, a doctor struggling under an impossible workload, a policy-maker trying to balance innovation and access, or the investor weighing risks and returns, human stories are what really matter. Because they reveal the forces shaping China’s role in the future of health - and, by extension, the rest of the world.
That’s where the China Health Pulse newsletter comes in.
What to expect:
Vital Signs - Key insights into major trends: biotech, health reform, digital health, geopolitics, and more.
Real Diagnosis - Timely deep dives into evolving health policies, market forces, and global influence.
Doctor’s Notes - Curated reads and listens: helping you cut through the noise and get straight to the best bits.
The CHP Podcast - Conversations and stories: from my own experiences to insights from the people on the ground.
Who am I?
I’m Ruby Wang, a practicing doctor and health consultant bridging the East-West divide in health. Born in China and raised in the UK, I’ve spent my career at the intersection of medicine, policy and industry, where I help to diagnose and contextualise everything from health reform to biotech strategy, pandemic response to global health diplomacy.
I’ve worked across government, the private sector, and global institutions, leading teams for the UK Foreign Office, the United Nations and multi-national organisations as well as start-ups. I founded LINTRIS Health, an award-winning consultancy that bridges East and West to help clients everywhere navigate the complex global health landscape that we live and work in today. Practicing medicine remains one of the most meaningful parts of my work, but I now split my time between China and the UK, moving between hospital wards, board rooms and policy meetings, translating clinical realities into strategy and regulatory jargon into actionable insights.
Why now?
China’s role in global health is too big to ignore, and too complex to be reduced to soundbites. But understanding it shouldn’t require a medical degree, a PhD in policy, or a corporate intelligence report.
I started China Health Pulse in order to create an accessible, informal space where I can break down these issues with clarity, as well as heart. A place to explore the big health questions that keep me brainstorming, where I can share the stories that don’t make it into mainstream news, and maybe even inject a little humour along the way.
Look out in late 2026 for my upcoming book on the global impact of China’s biotech and AI medicine rise. I also regularly write and comment in published media, including Nikkei Asia, The Wire China, The Economist, The Telegraph etc.
Apart from my China focus, I also advise and research more broadly on healthtech, health management and global/public health. Do get in touch on any of these areas, I’d love to hear from you.
